| Insomnia Relief Insomnia-Anxiety Omega Receptors Stay Asleep Sleep Efficiency Sleep Architecture Unique Benzodiazepine Metabolism Flexible Dosing Patient Assistance |
Facts about InsomniaInsomnia is a common term for the inability to sleep. That might mean difficulty falling asleep, staying asleep, rising too early, or experiencing unrefreshed sleep. Most people experience insomnia at one time or another during their life, however insomnia generally occurs more frequently in women, people over age 60, or those with a history of depression.¹ Students, shift workers, travelers, or those under stress or in pain are also vulnerable to sleep loss.² While insomnia is more common in these groups, it does not diminish their need for sleep. While a number of factors can contribute to insomnia, such as environmental, medical, or lifestyle issues, some of the most common reasons are psychological including stress at work, general anxiety, family issues, or financial worries. Traveling or jet lag can also contribute to sleep difficulties. According to the National Sleep Foundation (NSF), two-thirds of Americans have sleep problems; 56% of adults reported experiencing symptoms of insomnia a few nights a week or more, yet only half of those people are being treated by a healthcare provider.² Insomnia can take a variety of forms:
Transient and intermittent insomnia However, if daytime drowsiness exists and impedes normal functioning, or if short-term insomnia continues, a short-acting sleep agent may prove helpful. Chronic insomnia The use of sleeping pills can often help relieve insomnia, although, as with all medications, there are potential side effects. Sleeping pills are generally prescribed at the lowest effective dose and for the shortest duration of time to relieve symptoms.¹ A number of prescription sleep agents are available from your physician should you need medication. |
For additional |
|
| About Restoril |
About Insomnia |
For Healthcare Professionals |
Resources |
Home |
Legal Statements |
Privacy Policy |
![]() This web site is intended only for residents of the U.S.
Restoril™ is a registered trademark of Mallinckrodt Inc.
©2008 Mallinckrodt Pharmaceuticals. All Rights Reserved. Website Development by Strategic eCommerce Solutions. Important safety information: Restoril™ is indicated for the short-term treatment of insomnia (generally 7 to 10 days). The failure of insomnia to remit after 7 to 10 days of treatment may indicate the presence of a primary psychiatric and/or medical illness that should be evaluated. Restoril™ is contraindicated in women who are pregnant or may become pregnant because of the potential risk to the fetus. The most common side effects of Restoril™ are drowsiness, dizziness, lightheadedness, and difficulty with coordination. Severe allergic reactions have been reported in patients taking sedative-hypnotics, including Restoril™. Complex behaviors such as “sleep driving” have also been reported. Although behaviors such as “sleep driving” may occur with Restoril™ alone at therapeutic doses, the use of alcohol or other CNS depressants with Restoril™ appears to increase the risk of these unusual behaviors, as does the use of Restoril™ doses exceeding the maximum recommended dose. Use extreme care while doing anything that requires complete alertness, such as driving a car, operating machinery, or piloting an aircraft. For more information about Restoril™ (temazepam) capsules, please read the complete prescribing information. References: |
||